We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biden Administration Proposes Sweeping Change for U.S. Drug Manufacturing
Biden Administration Proposes Sweeping Change for U.S. Drug Manufacturing
Saying that the COVID-19 crisis “laid bare new and longstanding drug supply-chain vulnerabilities,” the Biden administration yesterday proposed sweeping changes for the U.S. drug industry to restore its control over drug ingredients and quality.